Uncategorized

NeoGenesis Capital Launches Fund Focused On Superintelligence And Synthetic Biology

NeoGenesis Capital has launched as a venture capital firm focused on programmable biology at the intersection of superintelligence and synthetic biology and has announced the initial close of its first fund.

​Read More

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *